Concordance Between Watson for Oncology and a Multidisciplinary Clinical Decision-Making Team for Gastric Cancer and the Prognostic Implications: Retrospective Study

Journal of Medical Internet Research
Yulong TianYanbing Zhou

Abstract

With the increasing number of cancer treatments, the emergence of multidisciplinary teams (MDTs) provides patients with personalized treatment options. In recent years, artificial intelligence (AI) has developed rapidly in the medical field. There has been a gradual tendency to replace traditional diagnosis and treatment with AI. IBM Watson for Oncology (WFO) has been proven to be useful for decision-making in breast cancer and lung cancer, but to date, research on gastric cancer is limited. This study compared the concordance of WFO with MDT and investigated the impact on patient prognosis. This study retrospectively analyzed eligible patients (N=235) with gastric cancer who were evaluated by an MDT, received corresponding recommended treatment, and underwent follow-up. Thereafter, physicians inputted the information of all patients into WFO manually, and the results were compared with the treatment programs recommended by the MDT. If the MDT treatment program was classified as "recommended" or "considered" by WFO, we considered the results concordant. All patients were divided into a concordant group and a nonconcordant group according to whether the WFO and MDT treatment programs were concordant. The prognoses of the two gro...Continue Reading

References

Feb 11, 2015·Annals of Surgical Oncology·Minoru FukuchiErito Mochiki
Aug 2, 2017·ESMO Open·Alessandra Curioni-Fontecedro
Mar 17, 2018·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu·Wanqing ChenJie He
Oct 1, 2018·BMC Cancer·S HollunderI G H Schmidt-Wolf

❮ Previous
Next ❯

Citations

Jun 15, 2020·Clinical Pharmacology and Therapeutics·Nicholas J SchorkJeffrey Trent
Dec 2, 2020·Zentralblatt für Chirurgie·Dirk WilhelmHubertus Feussner
Oct 1, 2020·Computational and Structural Biotechnology Journal·Zodwa DlaminiRahaba Marima
Mar 25, 2021·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Lotte KeikesMartijn G H Van Oijen
Jun 18, 2021·World Journal of Gastroenterology : WJG·Sohan Lal SolankiShailesh V Shrikhande

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection

Software Mentioned

WFO
SPSS
IBM Watson for Oncology ( WFO )

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.